Comparing the Efficiency of Closed System Transfer Devices for Compounding devteam on May 6, 2022 Post navigation Previous: Previous post: Development of an On-Going Sterility Monitoring Program for Single-Use Vials Undergoing Multiple Access Following Application of a Closed System Transfer DeviceNext: Next post: Treatment time, ease of use and cost associated with use of Equashield™, PhaSeal®, or no closed system transfer device for administration of cancer chemotherapy to a dog mode